Burny A, Bruck C, Cleuter Y, et al. Bovine leukemia virus, a versatile agent with various pathogenic effects in various animal species. Cancer Res 1985 ; 45 : 4578s-4582s.
Katoh I, Yoshinaka Y, Ikawa Y. Bovine leukemia virus trans-activator p38tax activates heterologous promoters with a common sequence known as a cAMP-responsive element or the binding site of a cellular transcription factor ATF. EMBO J 1989 ; 8 : 497-503.
Derse D, Casey JW. Two elements in the bovine leukemia virus long terminal repeat that regulate gene expression. Science 1986 ; 231 : 1437-40.
Merezak C, Pierreux C, Adam E, et al. Suboptimal enhancer sequences are required for efficient bovine leukemia virus propagation in vivo : implications for viral latency. J Virol 2001 ; 75 : 6977-88.
Calomme C, Dekoninck A, Nizet S, et al. Overlapping CRE and E box motifs in the enhancer sequences of the bovine leukemia virus 5′ long terminal repeat are critical for basal and acetylation-dependent transcriptional activity of the viral promoter : implications for viral latency. J Virol 2004 ; 78 : 13848-64.
Brooks PA, Cockerell GL, Nyborg JK. Activation of BLV transcription by NF-kappa B and Tax. Virology 1998 ; 243 : 94-8.
Dekoninck A, Calomme C, Nizet S, et al. Identification and characterization of a PU.1/Spi-B binding site in the bovine leukemia virus long terminal repeat. Oncogene 2003 ; 22 : 2882-96.
Xiao J, Buehring GC. In vivo protein binding and functional analysis of cis-acting elements in the U3 region of the bovine leukemia virus long terminal repeat. J Virol 1998 ; 72 : 5994-6003.
Kiermer V, Van Lint C, Briclet D, et al. An interferon regulatory factor binding site in the U5 region of the bovine leukemia virus long terminal repeat stimulates Tax-independent gene expression. J Virol 1998 ; 72 : 5526-34.
Derse D. trans-acting regulation of bovine leukemia virus mRNA processing. J Virol 1988 ; 62 : 1115-9.
Alexandersen S, Carpenter S, Christensen J, et al. Identification of alternatively spliced mRNAs encoding potential new regulatory proteins in cattle infected with bovine leukemia virus. J Virol 1993 ; 67 : 39-52.
Kerkhofs P, Heremans H, Burny A, Kettmann R, Willems L. In vitro and in vivo oncogenic potential of bovine leukemia virus G4 protein. J Virol 1998 ; 72 : 2554-9.
Lefebvre L, Ciminale V, Vanderplasschen A, et al. Subcellular localization of the bovine leukemia virus R3 and G4 accessory proteins. J Virol 2002 ; 76 : 7843-54.
Willems L, Kerkhofs P, Dequiedt F, et al. Attenuation of bovine leukemia virus by deletion of R3 and G4 open reading frames. Proc Natl Acad Sci USA 1994 ; 91 : 11532-6.
Adam E, Kerkhofs P, Mammerickx M, et al. Involvement of the cyclic AMP-responsive element binding protein in bovine leukemia virus expression in vivo. J Virol 1994 ; 68 : 5845-53.
Willems L, Heremans H, Chen G, et al. Cooperation between bovine leukaemia virus transactivator protein and Ha-ras oncogene product in cellular transformation. EMBO J 1990 ; 9 : 1577-81.
Merimi M, Klener P, Szynal M, et al. Complete suppression of viral gene expression is associated with the onset and progression of lymphoid malignancy : observations in bovine leukemia virus-infected sheep. Retrovirology 2007 ; 4 : 51.
Meas S, Seto J, Sugimoto C, et al. Infection of bovine immunodeficiency virus and bovine leukemia virus in water buffalo and cattle populations in Pakistan. J Vet Med Sci 2000 ; 62 : 329-31.
Mammerickx M, Porteteile D, Burny A. Experimental cross-transmissions of bovine leukemia virus (BLV) between several animal species. Zentralbl Veterinarmed B 1981 ; 28 : 69-81.
Straub OC. Natural and experimental transmissions of bovine leukaemia virus. In : Burny A, Mammerickx M, eds. Enzootic bovine leucosis and bovine leukemia virus. Boston : Martinus Nijhoff, 1987.
Levy D, Kettmann R, Marchand P, Djilali S, Parodi AL. Selective tropism of bovine leukemia virus (BLV) for surface immunoglobulin-bearing ovine B lymphocytes. Leukemia 1987 ; 1 : 463-5.
Mirsky ML, Olmstead CA, Da Y, Lewin HA. The prevalence of proviral bovine leukemia virus in peripheral blood mononuclear cells at two subclinical stages of infection. J Virol 1996 ; 70 : 2178-83.
Mammerickx M, Portetelle D, de Clercq K, Burny A. Experimental transmission of enzootic bovine leukosis to cattle, sheep and goats : infectious doses of blood and incubation period of the disease. Leuk Res 1987 ; 11 : 353-8.
Wilesmith JW. Needle transmission of bovine leucosis virus. Vet Rec 1979 ; 104 : 107.
Hasselschwert DL, French DD, Hribar LJ, et al. Relative susceptibility of beef and dairy calves to infection by bovine leukemia virus via tabanid (Diptera : Tabanidae) feeding. J Med Entomol 1993 ; 30 : 472-3.
Burny A, Cleuter Y, Kettmann R, et al. Bovine leukaemia : facts and hypotheses derived from the study of an infectious cancer. Cancer Surv 1987 ; 6 : 139-59.
Williams DL, Amborski GF, Davis WC. Enumeration of T and B lymphocytes in bovine leukemia virus-infected cattle, using monoclonal antibodies. Am J Vet Res 1988 ; 49 : 1098-103.
Taylor BC, Stott JL, Thurmond MA, Picanso JP. Alteration in lymphocyte subpopulations in bovine leukosis virus-infected cattle. Vet Immunol Immunopathol 1992 ; 31 : 35-47.
Burny A, Bruck C, Chantrenne H, et al. In : Klein G, ed. Bovine leukemia virus : molecular biology and epidemiology. New York : Viral Oncology Raven Press, 1980 : 231-89.
Kettmann R, Cleuter Y, Mammerickx M, et al. Genomic integration of bovine leukemia provirus : comparison of persistent lymphocytosis with lymph node tumor form of enzootic. Proc Natl Acad Sci USA 1980 ; 77 : 2577-81.
Esteban EN, Thorn RM, Ferrer JF. Characterization of the blood lymphocyte population in cattle infected with the bovine leukemia virus. Cancer Res 1985 ; 45 : 3225-30.
Fossum C, Burny A, Portetelle D, Mammerickx M, Morein B. Detection of B and T cells, with lectins or antibodies, in healthy and bovine leukemia virus-infected cattle. Vet Immunol Immunopathol 1988 ; 18 : 269-78.
Ferrer JF, Marshak RR, Abt DA, Kenyon SJ. Relationship between lymphosarcoma and persistent lymphocytosis in cattle : a review. J Am Vet Med Assoc 1979 ; 175 : 705-8.
Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980 ; 77 : 7415-9.
Kalyanaraman VS, Sarngadharan MG, Robert-Guroff M, Miyoshi I, Golde D, Gallo RC. A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia. Science 1982 ; 218 : 571-3.
Mammerickx M, Palm R, Portetelle D, Burny A. Experimental transmission of enzootic bovine leukosis to sheep : latency period of the tumoral disease. Leukemia 1988 ; 2 : 103-7.
Willems L, Portetelle D, Kerkhofs P, et al. In vivo transfection of bovine leukemia provirus into sheep. Virology 1992 ; 189 : 775-7.
Willems L, Burny A, Collete D, et al. Genetic determinants of bovine leukemia virus pathogenesis. AIDS Res Hum Retroviruses 2000 ; 16 : 1787-95.
Florins A, Gillet N, Boxus M, Kerkhofs P, Kettmann R, Willems L. Even BLV attenuated proviruses can be pathogenic in sheep. J Virol 2007 ; (in press).
Debacq C, Gillet N, Asquith B, et al. Peripheral blood B-cell death compensates for excessive proliferation in lymphoid tissues and maintains homeostasis in bovine leukemia virus-infected sheep. J Virol 2006 ; 80 : 9710-9.
Debacq C, Asquith B, Kerkhofs P, et al. Increased cell proliferation, but not reduced cell death, induces lymphocytosis in bovine leukemia virus-infected sheep. Proc Natl Acad Sci USA 2002 ; 99 : 10048-53.
Asquith B, Debacq C, Florins A, et al. Quantifying lymphocyte kinetics in vivo using carboxyfluorescein diacetate succinimidyl ester (CFSE). Proc Biol Sci 2006 ; 273 : 1165-71.
Florins A, Gillet N, Asquith B, et al. Spleen-dependent turnover of CD11b peripheral blood B lymphocytes in bovine leukemia virus-infected sheep. J Virol 2006 ; 80 : 11998-2008.
Florins A, Gillet N, Asquith B, et al. Cell dynamics and immune response to BLV infection : a unifying model. Front Biosci 2007 ; 12 : 1520-31.
Willems L, Grimonpont C, Kerkhofs P, et al. Phosphorylation of bovine leukemia virus Tax protein is required for in vitro transformation but not for transactivation. Oncogene 1998 ; 16 : 2165-76.
Lagarias DM, Radke K. Transcriptional activation of bovine leukemia virus in blood cells from experimentally infected, asymptomatic sheep with latent infections. J Virol 1989 ; 63 : 2099-107.
Jensen WA, Rovnak J, Cockerell GL. In vivo transcription of the bovine leukemia virus tax/rex region in normal and neoplastic lymphocytes of cattle and sheep. J Virol 1991 ; 65 : 2484-90.
Achachi A, Florins A, Gillet N, et al. Valproate activates bovine leukemia virus gene expression, triggers apoptosis, and induces leukemia/lymphoma regression in vivo. Proc Natl Acad Sci USA 2005 ; 102 : 10309-14.
Lezin A, Gillet N, Olindo S, et al. Histone deacetylase mediated transcriptional activation reduces proviral loads in HTLV-1-associated myelopathy/tropical spastic paraparesis patients. Blood 2007 ; 110 : 3722-8.
Weinberg RA. Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis. Cancer Res 1989 ; 49 : 3713-21.
Moules V, Pomier C, Sibon D, et al. Fate of premalignant clones during the asymptomatic phase preceding lymphoid malignancy. Cancer Res 2005 ; 65 : 1234-43.
